Jones Packaging Invests in New Solid Dose Vial Line - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Jones Packaging Invests in New Solid Dose Vial Line


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 7

Jones Packaging has invested in a fully automated solid-dose plastic vial filling line. The line is operating in the company’s contract packaging services facility in the greater Toronto area and is capable of filling 12 million vials annually.

The fully integrated line also includes carding and blistering for a market-ready packaging solution. The Jones Printed Packaging division designs and manufactures the card and label components in-house for tighter control over timelines, costs, and quality. Jones services the entire North American market.

Source: Jones Packaging

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here